Catherine Knupp — Executive Vice President and President of Research & Development at Zoetis

Dr. Catherine A. Knupp has been President of Research & Development and an Executive Vice President of Zoetis Inc. since October 2012 and she leads its Global R&D function. Dr. Knupp served as Vice President of Pfizer's Veterinary Medicine Research and Development business unit from 2005 to 2012. Dr. Knupp joined Pfizer in July 2001 and held various positions, including Vice President of Pfizer's Michigan laboratories for Pharmacokinetics, Dynamics and Metabolism. Dr. Knupp led Pfizer's Michigan laboratories in pharmacokinetics, dynamics and metabolism and chaired the Midwest Exploratory Development Management Team in Pfizer Global Research and Development. She began her career in 1987 at Bristol-Myers Squibb where she held positions of increasing responsibility in drug metabolism and pharmacokinetics. This experience led to her appointment as executive director, Drug Metabolism and Pharmacokinetics. Her last position with that company was as vice president, Chemical Manufacturing Controls (CMC), where she was responsible for global CMC regulatory submissions. Dr. Knupp earned her Doctor of Veterinary Medicine (DVM) degree in 1985 from the University of Illinois, where she also received a master's degree in toxicology and a bachelor's degree in veterinary biosciences. She also earned another bachelor's degree in chemistry from Western Illinois University.